{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:34:40Z","timestamp":1784810080541,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":2931,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.bbmt.2006.12.452","type":"journal-article","created":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T07:23:05Z","timestamp":1171610585000},"page":"486-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["The International Prognostic Index Assessed at Relapse Predicts Outcomes of Autologous Transplantation for Diffuse Large-Cell Non-Hodgkin\u2019s Lymphoma in Second Complete or Partial Remission"],"prefix":"10.1016","volume":"13","author":[{"given":"Rachel E.","family":"Lerner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd E.","family":"DeFor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Weisdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda J.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2006.12.452_bib1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.12.452_bib2","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM199211053271903","article-title":"Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin\u2019s lymphoma","volume":"327","author":"Gordon","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.12.452_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1056\/NEJM199304083281409","article-title":"Treatment of non-Hodgkin\u2019s lymphoma","volume":"328","author":"Armitage","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.12.452_bib4","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.12.452_bib5","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin\u2019s lymphoma","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2006.12.452_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbmt.2003.09.015","article-title":"Autologous transplantation for diffuse aggressive non-Hodgkin lymphoma in first relapse or second remission","volume":"10","author":"Vose","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.12.452_bib7","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1365-2141.1996.437976.x","article-title":"The role of intensive therapy and autologous blood and marrow transplantation for chemotherapy-sensitive relapsed and primary refractory non-Hodgkin\u2019s lymphoma: identification of major prognostic groups","volume":"92","author":"Prince","year":"1996","journal-title":"Br J Haemat"},{"key":"10.1016\/j.bbmt.2006.12.452_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1200\/JCO.1993.11.6.1085","article-title":"Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin\u2019s lymphoma with cyclophosphamide, carmustustine, and etoposide","volume":"11","author":"Wheeler","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.12.452_bib9","first-page":"941","article-title":"Risk assessment in diffuse large cell lymphoma at first relapse","volume":"86","author":"Gugliemi","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2006.12.452_bib10","first-page":"3562","article-title":"The international prognostic index correlates to survival in patients with aggressive lymphoma in relapse: analysis of the PARMA trial","volume":"92","author":"Blay","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.12.452_bib11","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-12-3837","article-title":"Age-adjusted international prognostic index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma","volume":"102","author":"Hamlin","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.12.452_bib12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/10428190500054350","article-title":"Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin\u2019s lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation","volume":"46","author":"Jabbour","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2006.12.452_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdg008","article-title":"High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group","volume":"14","author":"Caballero","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2006.12.452_bib14","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting\u2014Arlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.12.452_bib15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.12.452_bib16","first-page":"1023","article-title":"Validity of the Ann Arbor staging classification for the non-Hodgkin\u2019s lymphomas","volume":"61","author":"Rosenberg","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.bbmt.2006.12.452_bib17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2006.12.452_bib18","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.bbmt.2006.12.452_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-s","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc [B]"},{"key":"10.1016\/j.bbmt.2006.12.452_bib20","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJM198706113162401","article-title":"High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin\u2019s lymphoma","volume":"316","author":"Philip","year":"1987","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2006.12.452_bib21","first-page":"594a","article-title":"Superiority of late over early intensification in relapsing\/refractory aggressive non-Hodgkin\u2019s lymphoma: a randomized study from the GELA: LNH RP 93","volume":"90","author":"Bosly","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.12.452_bib22","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood.V96.7.2399","article-title":"High-dose chemotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non-Hodgkin lymphoma: an intention-to-treat analysis","volume":"96","author":"Kewalramani","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2006.12.452_bib23","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2002.09.138","article-title":"Autologous transplantation for aggressive non-Hodgkin\u2019s lymphoma: results of a randomized trial evaluating graft source and minimal residual disease","volume":"20","author":"Vose","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2006.12.452_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1702795","article-title":"Autologous stem cell transplantation for clinically aggressive non-Hodgkin\u2019s lymphoma: the role of preparative regimens","volume":"27","author":"Salar","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2006.12.452_bib25","unstructured":"Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence\u2014SEER 9 Regs Public-Use, Nov 2004 Sub (1973-2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission."},{"key":"10.1016\/j.bbmt.2006.12.452_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/sj.bmt.1702833","article-title":"Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin\u2019s lymphoma in adults 60 years of age and older","volume":"27","author":"Gopal","year":"2001","journal-title":"Bone Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106013103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879106013103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:29:34Z","timestamp":1761056974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879106013103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1083879106013103"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.12.452","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The International Prognostic Index Assessed at Relapse Predicts Outcomes of Autologous Transplantation for Diffuse Large-Cell Non-Hodgkin\u2019s Lymphoma in Second Complete or Partial Remission","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2006.12.452","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}